Sfoglia per AUTORE
COPPOLA M
Collezione ASL Cuneo 2
Items : 25
Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective? in Journal of xenobiotics / J Xenobiot. 2022 Feb 7;12(1):41-52. doi: 10.3390/jox12010004.
2022
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Bevione F; Coppola M;
Opioid receptor antagonists and major depressive disorder: Current knowledge and future perspectives. in Medical hypotheses / Med Hypotheses. 2020 Nov;144:110215. doi: 10.1016/j.mehy.2020.110215. Epub 2020 Aug 26.
2020
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Potential Unconventional Medicines for the Treatment of SARS-CoV-2. in Drug research / Drug Res (Stuttg). 2020 Jun;70(6):286. doi: 10.1055/a-1170-4624. Epub 2020 May 19.
2020
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids. in Medical hypotheses / Med Hypotheses. 2020 Apr 22;140:109766. doi: 10.1016/j.mehy.2020.109766.
2020
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD. in Trends in psychiatry and psychotherapy / Trends Psychiatry Psychother. 2019 Jan-Mar;41(1):83-86. doi: 10.1590/2237-6089-2017-0159. Epub 2019
2019
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Sacchetto G; Coppola M;
Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine. in Journal of psychoactive drugs / J Psychoactive Drugs. 2018 Sep-Oct;50(4):361-366. doi: 10.1080/02791072.2018.1471247. Epub 2018 Jun
2018
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patients. in Clinical nutrition (Edinburgh, Scotland) / Clin Nutr. 2018 Jun;37(3):1061-1065. doi: 10.1016/j.clnu.2017.05.004. Epub 2017 May 6.
2018
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
Are physicians fully aware of the potential transgenerational and multigenerational effects of a large opioid misuse in the population? in Journal of opioid management / J Opioid Manag. 2018 Jul/Aug;14(4):237. doi: 10.5055/jom.2018.0454.
2018
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder. in BMC psychiatry / BMC Psychiatry. 2017 May 12;17(1):181. doi: 10.1186/s12888-017-1342-y.
2017
ASL Cuneo 1
ASL Città di Torino
ASL Cuneo 2
ASL Cuneo 1
ASL Città di Torino
ASL Cuneo 2
Picci RL; Nibbio G; Cuniberti F; Ascheri D; Oliva F; Mondola R; Coppola M;
Opioid receptor antagonists in the treatment of pathological gambling. in Journal of opioid management / J Opioid Manag. 2017 Jul/Aug;13(4):205-206. doi: 10.5055/jom.2017.0388.
2017
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up. in Journal of psychoactive drugs / J Psychoactive Drugs. 2017 Jul-Aug;49(3):262-265. doi: 10.1080/02791072.2017.1316431. Epub 2017 Apr
2017
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
4,4'-DMAR: chemistry, pharmacology and toxicology of a new synthetic stimulant of abuse. in Basic & clinical pharmacology & toxicology / Basic Clin Pharmacol Toxicol. 2015 Jul;117(1):26-30. doi: 10.1111/bcpt.12399. Epub 2015 Apr 19.
2015
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
AH-7921: a new synthetic opioid of abuse. in Drug and alcohol review / Drug Alcohol Rev. 2015 Jan;34(1):109-10. doi: 10.1111/dar.12216. Epub 2014 Oct 10.
2015
ASL Cuneo 2
ASL Cuneo 2
Coppola M; Mondola R;
Is there a role for palmitoylethanolamide in the treatment of depression? in Medical hypotheses / Med Hypotheses. 2014 May;82(5):507-11. doi: 10.1016/j.mehy.2013.12.016. Epub 2014 Mar 3.
2014
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
Cannabis consumption systemic adverse effects. in International journal of high risk behaviors & addiction / Int J High Risk Behav Addict. 2014 May 28;3(2):e18627. doi: 10.5812/ijhrba.18627. eCollection 2014 J
2014
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. in Medical hypotheses / Med Hypotheses. 2014 Dec;83(6):673-6. doi: 10.1016/j.mehy.2014.09.015. Epub 2014 Oct 13.
2014
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Palmitoylethanolamide: from endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence. in Medical hypotheses / Med Hypotheses. 2013 Oct;81(4):619-22. doi: 10.1016/j.mehy.2013.07.016. Epub 2013 Jul 26.
2013
ASL Cuneo 2
ASL Cuneo 2
Mondola R; Coppola M;
5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects. in Toxicology letters / Toxicol Lett. 2013 Mar 27;218(1):24-9. doi: 10.1016/j.toxlet.2013.01.008. Epub 2013 Jan 21.
2013
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics? in Medical hypotheses / Med Hypotheses. 2013 Jul;81(1):10-4. doi: 10.1016/j.mehy.2013.03.030. Epub 2013 Apr 19.
2013
ASL Cuneo 2
ASL Cuneo 2
Mondola R; Coppola M;
4-methylamphetamine (4-MA): chemistry, pharmacology and toxicology of a new potential recreational drug. in Mini reviews in medicinal chemistry / Mini Rev Med Chem. 2013 Dec;13(14):2097-101. doi: 10.2174/13895575113136660106.
2013
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Methoxetamine: from drug of abuse to rapid-acting antidepressant. in Medical hypotheses / Med Hypotheses. 2012 Oct;79(4):504-7. doi: 10.1016/j.mehy.2012.07.002. Epub 2012 Jul 21.
2012
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". in Toxicology letters / Toxicol Lett. 2012 Jun 1;211(2):144-9. doi: 10.1016/j.toxlet.2012.03.009. Epub 2012 Mar 21.
2012
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
Research chemicals marketed as legal highs: the case of pipradrol derivatives. in Toxicology letters / Toxicol Lett. 2012 Jul 7;212(1):57-60. doi: 10.1016/j.toxlet.2012.04.019. Epub 2012 May 5.
2012
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;
3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. in Toxicology letters / Toxicol Lett. 2012 Jan 5;208(1):12-5. doi: 10.1016/j.toxlet.2011.10.002. Epub 2011 Oct 8.
2012
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Coppola M; Mondola R;
Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: a review. in Nordic journal of psychiatry / Nord J Psychiatry. 2012 Apr;66(2):73-8. doi: 10.3109/08039488.2011.605172. Epub 2011 Aug 23.
2012
ASL Cuneo 2
ASL Cuneo 1
ASL Cuneo 2
ASL Cuneo 1
Mondola R; Coppola M;